Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 172

Similar articles for PubMed (Select 20571168)

1.

Low serum zinc levels in an endemic area of visceral leishmaniasis in Bihar, India.

Mishra J, Carpenter S, Singh S.

Indian J Med Res. 2010 Jun;131:793-8.

2.

Combination Treatment for Visceral Leishmaniasis Patients Co-infected with Human Immunodeficiency Virus in India.

Mahajan R, Das P, Isaakidis P, Sunyoto T, Sagili KD, Lima MA, Mitra G, Kumar D, Pandey K, Van Geertruyden JP, Boelaert M, Burza S.

Clin Infect Dis. 2015 Jun 30. pii: civ530. [Epub ahead of print]

PMID:
26129756
3.

A comparative evaluation of the performance of commercially available rapid immunochromatographic tests for the diagnosis of visceral leishmaniasis in Bangladesh.

Ghosh P, Hasnain MG, Ghosh D, Hossain F, Baker J, Boelaert M, Rijal S, Mondal D.

Parasit Vectors. 2015 Jun 16;8(1):331. doi: 10.1186/s13071-015-0935-x.

4.

Fasciolopsiasis: Endemic focus of a neglected parasitic disease in Bihar.

Achra A, Prakash P, Shankar R.

Indian J Med Microbiol. 2015 Jul-Sep;33(3):364-8. doi: 10.4103/0255-0857.158554.

5.

Epidemiological Feature of Visceral Leishmaniasis in China, 2004-2012.

Zhao S, Li Z, Zhou S, Zheng C, Ma H.

Iran J Public Health. 2015 Jan;44(1):51-9.

6.

Development of Leishmania vaccines in the era of visceral leishmaniasis elimination.

Engwerda CR, Matlashewski G.

Trans R Soc Trop Med Hyg. 2015 Jul;109(7):423-4. doi: 10.1093/trstmh/trv039. Epub 2015 Jun 4.

PMID:
26048873
7.

Hemophagocytic lymphohistiocytosis in children with visceral leishmaniasis.

Blázquez-Gamero D, Domínguez-Pinilla N, Chicharro C, Negreira S, Galán P, Pérez-Gorricho B, Calvo C, Prieto L, De la Parte M, Otheo E, Vivanco JL, Ruiz-Contreras J; Madrid Leishmaniasis Study Group.

Pediatr Infect Dis J. 2015 Jun;34(6):667-9. doi: 10.1097/INF.0000000000000685.

PMID:
25970110
8.

Association of Ficolin-2 Serum Levels and FCN2 Genetic Variants with Indian Visceral Leishmaniasis.

Mishra A, Antony JS, Sundaravadivel P, Tong HV, Meyer CG, Jalli RD, Velavan TP, Thangaraj K.

PLoS One. 2015 May 12;10(5):e0125940. doi: 10.1371/journal.pone.0125940. eCollection 2015.

9.

IL10 Variant g.5311A Is Associated with Visceral Leishmaniasis in Indian Population.

Mishra A, Nizamuddin S, Arekatla G, Prakash S, Dewangan H, Dominic A, Mishra A, Sudhakar DV, Parine NR, Tupperwar NC, Thangaraj K.

PLoS One. 2015 May 5;10(5):e0124559. doi: 10.1371/journal.pone.0124559. eCollection 2015.

10.

Optimizing Insecticide Allocation Strategies Based on Houses and Livestock Shelters for Visceral Leishmaniasis Control in Bihar, India.

Gorahava KK, Rosenberger JM, Mubayi A.

Am J Trop Med Hyg. 2015 May 4. pii: 14-0612. [Epub ahead of print]

PMID:
25940194
11.

Is the polymorphism at position -1082 of IL-10 gene associated with visceral leishmaniasis?

Hajilooi M, Ahmadi A, Lotfi P, Matini M, Jafari D, Bazmani A, Momeni M.

Iran J Public Health. 2014 Aug;43(8):1107-12.

12.

Seroepidemiological survey of human visceral leishmaniasis in ilam province, west of iran in 2013.

Abdi J, Akhoundi B, Mohebali M, Ghaderipour A, Kakoee Z, Najafi F.

Iran J Parasitol. 2015 Jan-Mar;10(1):56-61.

13.

Evaluation of interleukin-8 -251 t/a polymorphisms in visceral leishmaniasis.

Hajilooi M, Abasi M, Bazmani A, Ahmadi A, Matini M, Solgi G, Sardarian K.

J Res Health Sci. 2015 Winter;15(1):59-61.

14.

Knowledge of the population about visceral leishmaniasis transmission in endemic areas near the banks of the Mossoró River in northeastern Brazil.

de Amorim CF, Santos Albano Amóra S, Kazimoto TA, de Lima Costa KF, Silva LF, de Sousa ML, Freitas YB, Alves ND, Feijó FM.

Int J Environ Res Public Health. 2015 Mar 19;12(3):3343-57. doi: 10.3390/ijerph120303343.

15.

Heterogeneity of Leishmania donovani parasites complicates diagnosis of visceral leishmaniasis: comparison of different serological tests in three endemic regions.

Abass E, Kang C, Martinkovic F, Semião-Santos SJ, Sundar S, Walden P, Piarroux R, El Harith A, Lohoff M, Steinhoff U.

PLoS One. 2015 Mar 3;10(3):e0116408. doi: 10.1371/journal.pone.0116408. eCollection 2015.

16.

Arsenic exposure and outcomes of antimonial treatment in visceral leishmaniasis patients in Bihar, India: a retrospective cohort study.

Perry MR, Prajapati VK, Menten J, Raab A, Feldmann J, Chakraborti D, Sundar S, Fairlamb AH, Boelaert M, Picado A.

PLoS Negl Trop Dis. 2015 Mar 2;9(3):e0003518. doi: 10.1371/journal.pntd.0003518. eCollection 2015 Mar.

17.

Visceral leishmaniasis diagnosis and reporting delays as an obstacle to timely response actions in Nepal and India.

Boettcher JP, Siwakoti Y, Milojkovic A, Siddiqui NA, Gurung CK, Rijal S, Das P, Kroeger A, Banjara MR.

BMC Infect Dis. 2015 Feb 6;15:43. doi: 10.1186/s12879-015-0767-5.

18.

Association of leishmaniasis with TNF alpha promoter and SLC11A1 gene polymorphisms in patients of two endemic areas in Mexico.

Ortiz-Flores A, De la Rosa-López G, Zavaleta-Villa B, Chávez-López S, Pastor-Santiago J, Guzmán-Bracho C, Romero-Valdovinos M, Martínez-Hernández F, Olivo-Díaz A.

Microbes Infect. 2015 May;17(5):387-94. doi: 10.1016/j.micinf.2015.01.001. Epub 2015 Jan 17.

PMID:
25603101
19.

Targeted Immunology for Prevention and Cure of VL.

Ali N, Nakhasi HL, Valenzuela JG, Reis AB.

Front Immunol. 2014 Dec 19;5:660. doi: 10.3389/fimmu.2014.00660. eCollection 2014. No abstract available.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk